Based on the cancer response, BC can be divided into estrogen receptor(ER)-positive, progesterone receptor (PR)-positive, ER/PR-positive, human epidermal growth factor receptor-2 (HER2)-positive, and triple-negative breast cancer (TNBC) [1]. Here, PGR is linked to triple-negative breast carcinoma.